K
Originally published by KBC Top Storiestop
April 26, 2026
4h ago
WHO prequalifies first-ever malaria treatment for newborns and infants, adds new diagnostic tests

The World Health Organisation (WHO) has prequalified the first malaria treatment specifically designed for newborns and young infants (2–5kg), marking a major step in closing a long-standing treatment gap and improving safe access to care for vulnerable babies in malaria-endemi..
✨ Key Highlights
The World Health Organisation (WHO) has prequalified the first malaria treatment specifically for newborns and young infants, along with three new rapid diagnostic tests to combat parasite resistance.
- The new treatment is the first antimalarial formulation designed specifically for the youngest malaria patients, addressing a gap for approximately 30 million babies born annually in malaria-endemic areas.
- WHO Director-General Dr Tedros Adhanom Ghebreyesus highlighted these advancements as crucial in the fight to end malaria.
- The new diagnostic tests target a different parasite protein, addressing the issue of some malaria strains becoming "invisible" to older tests, which led to up to 80% of cases being missed in the Horn of Africa.
Continue Reading
Read the complete article from KBC Top Stories
Advertisement
Advertisement





